Thomas Rapp, PhD is a Research Fellow at Harvard. He is currently an associate professor in economics at Université Paris Descartes – Sorbonne Paris Cité. He is also adjunct director of the health economics research center at Université Paris Descartes – Sorbonne Paris Cité, where he leads the agenda to develop a research program that analyzes policies targeting frail elderly people who face autonomy loss risks. He holds a Ph.D and a Master’s degree in economics from the University of Paris Dauphine, a Maîtrise and a Bachelor degree in economics from the University of Toulouse Capitole (now Toulouse School of Economics).
Dr. Rapp’s research is focused on the economic evaluation of health policies and innovations targeting elderly people. He leads the health economics work package of a €54 million research grant from the Innovative Medicines Initiative (IMI), Europe’s largest public-private initiative aiming to speed up the development of better and safer medicines for patients. He participated in the definition of guidelines for economic evaluations of telemedicine at French Haute Autorité de Santé (2011-2013), the Strategic Committee for Health Care Industries at French Ministry of Industry (2010-2012), and he is a member of the Scientific Committee for the Evaluation of the PATHOS and AGGIR Tools at the Ministry of Health (since 2011). From 2011 to 2015, he was a member of the French National University Council in Economics. From 2015 to 2016, he received the Harkness Fellowship in health policy and practice from the Commonwealth Fund.
Rapp is also the director of the master’s degree in health economics at University Paris Sorbonne Abu Dhabi. His past positions have included research project leader at the University Hospital Toulouse, postdoctoral fellow at the University of Maryland and the Toulouse School of Economics, research and teaching assistant at University of Paris-Dauphine, and research assistant at CEPII, a French research institute affiliated with the Economic Policy Planning for the French Prime Minister.
He is a Co Editor of Value in Health, and he has published his research in several journals such as: Medical Care, Value in Health, Health Services Research, the European Journal of Health Economics, and Social Science and Medicine.
Sirven, N. & Rapp, T. (2016), The Dynamics of Hospital Use among Older People. Evidence for Europe using SHARE data, forthcoming 2016, Health Services Research.
Andrade, L., Rapp, T., Sevilla-Dedieu, C. (2016). Exploring the determinants of endocrinologist visits by patients with diabetes, The European Journal of Health Economics.
Sirven, N. & Rapp, T. (2016), The cost of frailty in France, Forthcoming, The European Journal of Health Economics.
Rapp, T. Chauvin, P. & Sirven, N. (2015). Are public subsidies effective to reduce emergency care use? Evidence from the PLASA study, Social Science and Medicine.
Rapp, T., Lacey, L., Ousset, PJ, Cowppli-Bony, P., Vellas, B., & Orgogozo, JM. (2015). An analysis of the public financial support eligibility rule for French dependent elders with Alzheimer’s disease, Value in Health.
Sirven, N. & Rapp, T. (2015), Preventing frailty and autonomy loss in Europe: A health economics perspective from the SPRINTT study, Aging Clinical and Experimental Research, Special Issue on frailty.
Rapp, T., Chauvin, P., Costa, N., Molinier, L. (2014). Health Economics Considerations in Neurodegenerative Disorders, in Luca Saba (Ed.), Imaging in Neurodegenerative Disorders, Oxford University Press.
Rapp, T. (2014), Patients’ diagnosis decisions in Alzheimer’s disease: The influence of family factors, Social Science & Medicine, Volume 118, October 2014, 9–16.
Rapp T, Andrieu, S., Molinier, L., Grand, A., Cantet, C., Mullins, C.D. & Vellas, B., (2012), Exploring the Relationship Between Alzheimer’s Disease Severity and Longitudinal Costs, 15 (3) May 2012, Value in Health.
Costa N, Derumeaux H, Rapp T, Garnault V, Ferlicoq L, Gillette S, Andrieu S, Vellas B, Lamure M, Grand A & Molinier L., (2012) Methodological considerations in Cost of Illness Studies on Alzheimer Disease, 2(1) Sep 2012, Health Economics Review.
Rapp, T., Grand, A., Cantet, C., Andrieu, S., Coley, N., Portet F., & Vellas, B. (2011). Public Financial support receipt and non-medical resource utilization in Alzheimer’s disease -Results from the PLASA study. Social Science & Medicine, 72(8), 1310-1316.
Rapp, T. (2010). Health Economics and Health Policy Issues in Alzheimer’s Disease, The Journal of Nutrition, Health and Aging, 14, 630-632.
Gustavsson, A., Jonsson, L., Rapp, T., Reynish, E., Ousset, P.J., Andrieu, S., Cantet, C., Winblad, B., Vellas, B. & Wimo, A. (2010) Differences in Resource Use and Costs of Dementia Care Between European Countries: Baseline Data from the ICTUS Study. The Journal of Nutrition, Health and Aging, 14, 648-654.
Barnet, B., Rapp, T., DeVoe, M., & Mullins, C.D. (2010). Reducing Repeat Childbearing in High Risk Adolescent Mothers: A Rebirth of Policy and Economic Considerations, Archives of Pediatrics & Adolescent Medicine, 164, 370-376.
Zuckerman, I., Rapp, T., Onukwugha, E., Davidoff, A., Choti, M., Gardner, J., Seal, B. & Mullins, C.D. (2009). Effect of Age on Survival Benefit of Adjuvant Chemotherapy in Elderly Stage III Colon Cancer Patients. Journal of the American Geriatrics Society, 57, 1403-1410.
Davidoff, A., Rapp, T., Onukwugha, E., Zuckerman, I., Hanna, N., Pandya, N., & Mullins, C.D. (2009). Trends in Disparities in Receipt of Adjuvant Therapy For Elderly Stage III Colon Cancer Patients: The Role of the Medical Oncologist Evaluation. Medical Care, 47, 1229-1236.